DUPILUMAB IMPROVES QUALITY OF LIFE IN CAREGIVERS OF CHILDREN WITH UNCONTROLLED MODERATE-TO-SEVERE ASTHMA: LIBERTY ASTHMA VOYAGE STUDY

被引：0
|
作者：
Fiocchi, A. G. [1 ]
Phipatanakul, W. [2 ]
Durrani, S. [3 ]
Cole, J. [4 ]
Msihid, J. [5 ]
Lederer, D. J. [6 ]
Hardin, M. [7 ]
Zhang, Y. [6 ]
Khan, A. H. [5 ]
机构：
[1] Bambino Gesu Childrens Hosp IRCCS, Rome, RM, Italy
[2] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA
[3] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
[4] OK Clin Res, Edmond, OK USA
[5] Sanofi, Chilly Mazarin, France
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Sanofi, Cambridge, MA USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
P38
引用
收藏
页码：S294 / S295
页数：3
相关论文
共 50 条
  • [21] Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study
    Tohda, Yuji
    Nakamura, Yoichi
    Fujisawa, Takao
    Ebisawa, Motohiro
    Arima, Kazuhiko
    Miyata, Masanori
    Takahashi, Yoshinori
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Patel, Naimish
    Graham, Neil M. H.
    Teper, Ariel
    ALLERGOLOGY INTERNATIONAL, 2020, 69 (04) : 578 - 587
  • [22] Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study
    Hanania, N. A.
    Bateman, E. D.
    Castro, M.
    Pavord, I. D.
    Papi, A.
    FitzGerald, J. M.
    Maspero, J. F.
    Katelaris, C.
    Singh, D.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Staudinger, H. W.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [23] Dupilumab improves asthma control and quality of life in children with uncontrolled persistent asthma
    Fiocchi, Alessandro
    Phipatanakul, Wanda
    Durrani, Sandy R.
    Cole, Jeremy
    Mao, Xuezhou
    Msihid, Jerome
    Lederer, David J.
    Hardin, Megan
    Zhang, Yi
    Khan, Asif H.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [24] Effect of Dupilumab in Korean Patients With Uncontrolled Moderate-to-Severe Asthma: A LIBERTY ASTHMA QUEST Sub-analysis
    Rhee, Chin Kook
    Park, Jung-Won
    Park, Heung-Woo
    Cho, You Sook
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2022, 14 (02) : 182 - 195
  • [25] Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study
    Maspero, Jorge F.
    Cardona, Guido
    Schonffeldt, Patricia
    Tolcachier, Alberto
    Gonzalez-Diaz, Sandra N.
    Yanez, Anahi
    Galvao, Clovis E.
    Msihid, Jerome
    Gall, Rebecca
    Siddiqui, Shahid
    Rowe, Paul J.
    Deniz, Yamo
    Jacob-Nara, Juby A.
    Djandji, Michel
    JOURNAL OF ASTHMA, 2023, 60 (05) : 981 - 990
  • [26] A Randomized, Controlled Phase 3 Study, LIBERTY ASTHMA QUEST, Evaluating the Efficacy and Safety of Dupilumab in Uncontrolled Moderate-to-Severe Asthma
    Castro, M.
    Corren, J.
    Pavord, I. D.
    Maspero, J. F.
    Wenzel, S. E.
    Rabe, K. F.
    Busse, W. W.
    Ford, L. B.
    Sher, L.
    FitzGerald, J.
    Katelaris, C.
    Tohda, Y.
    Zhang, B.
    Staudinger, H.
    Pirozzi, G.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Khan, A.
    Chao, J.
    Martincova, R.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [27] Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype
    Papadopoulos, Nikolaos
    Szefler, Stanley J.
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Domingo, Christian
    Daizadeh, Nadia
    Lederer, David J.
    Hardin, Megan
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Gall, Rebecca
    Ortiz, Benjamin
    Djandji, Michel
    Rowe, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [28] Dupilumab Reduces Severe Exacerbations and Improves Lung Function Regardless of Baseline Bronchodilator Reversibility in Patients with Uncontrolled Moderate-to-Severe Asthma Enrolled in the LIBERTY ASTHMA QUEST Study
    Pavord, I.
    Castro, M.
    Rabe, K. F.
    Hanania, N. A.
    Papi, A.
    FitzGerald, J. M.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Staudinger, H. W.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [29] Dupilumab efficacy in children with uncontrolled, moderate-to-severe type 2 asthma, with and without evidence of allergy, in the phase 3 VOYAGE study
    Papadopoulos, N. G.
    Szefler, S. J.
    Bacharier, L. B.
    Maspero, J. F.
    Domingo, C.
    Daizadeh, N.
    Lederer, D. J.
    Hardin, M.
    Jacob-Nara, J. A.
    Deniz, Y.
    Gall, R.
    Ortiz, B.
    Djandji, M.
    Rowe, P.
    ALLERGY, 2021, 76 : 175 - 176
  • [30] Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Allergic Asthma
    Miller, Mechelle A.
    Davis, Karla L.
    PEDIATRICS, 2020, 146 : S375 - S375
12345